Vibrant Pharmacuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 01-07-2024
- Paid Up Capital ₹ 1.00 M
as on 01-07-2024
- Company Age 20 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.97 M
as on 01-07-2024
- Revenue 29.22%
(FY 2022)
- Profit 23.85%
(FY 2022)
- Ebitda 8.82%
(FY 2022)
- Net Worth -1.11%
(FY 2022)
- Total Assets -8.82%
(FY 2022)
About Vibrant Pharmacuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.97 M.
Jitendra Vithalrao, Bhuveneshwari Jitendra, and Rathin Rabindra serve as directors at the Company.
- CIN/LLPIN
U24231GJ2004PTC044181
- Company No.
044181
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Vibrant Pharmacuticals Private Limited offer?
Vibrant Pharmacuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs, Eye Care Medicines, Hair Growth Medicine, Mineral Supplement, Multivitamin Syrup & Drops.
Who are the key members and board of directors at Vibrant Pharmacuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jitendra Vithalrao  | Director | 01-Apr-2009 | Current |
| Bhuveneshwari Jitendra | Director | 10-Feb-2010 | Current |
| Rathin Rabindra | Director | 01-Jul-2012 | Current |
Financial Performance of Vibrant Pharmacuticals.
Vibrant Pharmacuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 29.22% increase. The company also saw a substantial improvement in profitability, with a 23.85% increase in profit. The company's net worth dipped by a decrease of 1.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vibrant Pharmacuticals?
In 2021, Vibrant Pharmacuticals had a promoter holding of 96.00% and a public holding of 4.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Aug 2019 | ₹2.97 M | Open |
How Many Employees Work at Vibrant Pharmacuticals?
Unlock and access historical data on people associated with Vibrant Pharmacuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vibrant Pharmacuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vibrant Pharmacuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
